Cite
Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe.
MLA
Jonker, Carla J., et al. “Contribution of Patient Registries to Regulatory Decision Making on Rare Diseases Medicinal Products in Europe.” Frontiers in Pharmacology, vol. 13, Aug. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fphar.2022.924648.
APA
Jonker, C. J., Bakker, E., Kurz, X., & Plueschke, K. (2022). Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe. Frontiers in Pharmacology, 13, 1–9. https://doi.org/10.3389/fphar.2022.924648
Chicago
Jonker, Carla J., Elisabeth Bakker, Xavier Kurz, and Kelly Plueschke. 2022. “Contribution of Patient Registries to Regulatory Decision Making on Rare Diseases Medicinal Products in Europe.” Frontiers in Pharmacology 13 (August): 1–9. doi:10.3389/fphar.2022.924648.